Identification of a glucocorticoid response element in the human γ chain fibrinogen promoter

Thrombosis and Haemostasis

Volumn 79, Issue 6, 1998, Pages 1144-1150

  Asselta, Rosanna ^a   Duga, Stefano ^a   Modugno, Michele ^a   Malcovati, Massimo ^a   Tenchini, Maria Luisa ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Dipartimento di Biologia e Genetica per le Scienze Mediche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FIBRINOGEN; GLUCOCORTICOID; LUCIFERASE;

ARTICLE; CELL STRAIN HEPG2; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

EID: 0031831969     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615031     Document Type: Article

References (13)

1. Doolittle RF. Fibrinogen and fibrin. Ann Rev Biochem 1984; 53: 195-229.
2. Marino MW, Fuller GM, Elder FFB. Chromosomal localization of human and rat Aα, Bβ, and γ fibrinogen genes by in situ hybridization. Cytogen Cell Genet 1986; 42: 36-41.
3. Kant JA, Fornace AJJr, Save D, Simon MI, McBride OW, Crabtree GR. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-8.
4. Roy S, Overton O, Redman C. Overexpression of any fibrinogen chain by HepG2 cells specifically elevates the expression of the other two chains. J Biol Chem 1994; 269: 691-5.
5. Roberts LR, Holland LJ. Coordinate transcriptional regulation of the three fibrinogen subunit genes by glucocorticoids in cultured primary liver cells from Xenopus laevis. Endocrinology 1993; 132: 2563-70.
6. Blombäck B. Fibrinogen structure, activation, polymerization and fibrin gel structure. Thromb Res 1994; 75: 327-8.
7. Hettasch JM, Bolyard MG, Lord ST. The residues AGDV of recombinant γ chains of human fibrinogen must be carboxy-terminal to support human platelet aggregation. Thromb Haemost 1992; 68: 701-6.
8. De la Serna G. Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature. J Fam Pract 1994; 39: 468-77.
9. Mannucci PM, Mari D. Fibrinogen as a model protein in epidemiological studies. Fibrinolysis 1993; 7: 51-2.
10. Kushner I. The acute-phase response: an overview. Methods Enzymol 1988; 163: 373-83.
11. Higazi AA, Barghouti II, Ayesh S, Mayer M, Matzner Y. Inhibition of neutrophil activation by fibrinogen. Inflammation 1994; 18: 525-35.
12. Baumann H, Prowse KR, Marinkovic S, Won KA, Jahries GP. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann NY Acad Sci 1989; 557: 280-95.
13. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253-78.